U.S. RESEARCH ROUNDUP-Bank Ozk, Bunge, Littelfuse

Cerence

07/07/2022 08:18

July 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bank Ozk, Bunge and Littelfuse, on Thursday. 
    
    HIGHLIGHTS
     * Bank Ozk  OZK.O : Wells Fargo cuts to equal weight from overweight
     * Bunge Ltd  BG.N : JP Morgan raises to overweight from neutral    
     * Littelfuse Inc  LFUS.O : Baird cuts to neutral from outperform     
     * Rover Group Inc  ROVR.O : JP Morgan initiates coverage with neutral rating; PT $5 
    
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order. 
    
     * Alector Inc  ALEC.O : Mizuho initiates coverage with buy rating; target price $15 
     * Ameriprise Financial Inc  AMP.N : Credit Suisse cuts target price to $312 from $348 
     * Amphenol Corp  APH.N : Baird cuts target price to $76 from $85 
     * ArcelorMittal SA  MT.N : Jefferies cuts target price to $43.7 from $50.6 
     * Archer-Daniels-Midland Co  ADM.N : JP Morgan cuts target price to $83 from $93 
     * Assetmark Financial Holdings Inc  AMK.N : Jefferies cuts target price to $20 from $24 
     * Associated Banc-Corp  ASB.N : Wells Fargo cuts target price to $25 from $28 
     * AstraZeneca  AZN.O : Jefferies cuts target price to $58.5 from $59 
     * Athira pharma Inc  ATHA.O : Mizuho initiates coverage with buy rating; target price $6 
     * Banc of California Inc  BANC.N : Wells Fargo cuts target price to $23 from $25 
     * Bank Ozk  OZK.O : Wells Fargo cuts to equal weight from overweight
     * Bank Ozk  OZK.O : Wells Fargo cuts target price to $42 from $58 
     * Bankunited Inc  BKU.N : Wells Fargo cuts target price to $40 from $50 
     * Bioxcel Therapeutics Inc  BTAI.O : Mizuho initiates coverage with buy rating; PT $19 
     * Bok Financial Corp  BOKF.O : Wells Fargo cuts target price to $85 from $105 
     * BorgWarner Inc  BWA.N : Baird cuts target price to $41 from $46 
     * Bunge Ltd  BG.N : JP Morgan raises to overweight from neutral
     * Bunge Ltd  BG.N : JP Morgan cuts target price to $106 from $130 
     * CBRE Group Inc  CBRE.N : JP Morgan cuts target price to $93 from $116 
     * Cerence Inc  CRNC.O : Baird cuts target price to $29 from $34 
     * Cerevel Therapeutics Holdings Inc  CERE.O : Mizuho initiates coverage with neutral rating
     * Cerevel Therapeutics Holdings Inc  CERE.O : Mizuho initiates coverage with target $30 
     * Citizens Financial Group Inc  CFG.N : RBC cuts target price to $55 from $58 
     * Commerce Bancshares Inc  CBSH.O : Wells Fargo cuts target price to $65 from $70 
     * Cummins Inc  CMI.N : Baird cuts target price to $210 from $215 
     * Cytomx Therapeutics Inc  CTMX.O : BTIG cuts target price to $8 from $16 
     * Darling Ingredients Inc  DAR.N : JP Morgan cuts target price to $83 from $90 
     * Fate Therapeutics Inc  FATE.O : Truist Securities cuts target price to $51 from $75 
     * First Hawaiian Inc  FHB.O : Wells Fargo cuts target price to $24 from $26 
     * First Republic Bank  FRC.N : Wells Fargo cuts target price to $145 from $165 
     * focus Financial Partners Inc  FOCS.O : Jefferies cuts target price to $53 from $70 
     * Gentex Corp  GNTX.O : Baird cuts target price to $33 from $34 
     * Gentherm Inc  THRM.O : Baird cuts target price to $80 from $87 
     * Harmony Biosciences Holdings Inc  HRMY.O : Mizuho initiates coverage with buy rating
     * Harmony Biosciences Holdings Inc  HRMY.O : Mizuho initiates coverage with target $64 
     * Intercontinental Exchange Inc  ICE.N : Raymond James raises target price to $129 from $126 
     * Intra-Cellular Therapies Inc  ITCI.O : Mizuho initiates coverage with buy rating
     * Intra-Cellular Therapies Inc  ITCI.O : Mizuho initiates coverage with target price $75 
     * Jones Lang LaSalle Inc  JLL.N : JP Morgan cuts target price to $257 from $313 
     * Lamb Weston Holdings Inc  LW.N : JP Morgan raises target price to $82 from $77 
     * Littelfuse Inc  LFUS.O : Baird cuts target price to $269 from $289 
     * Littelfuse Inc  LFUS.O : Baird cuts to neutral from outperform 
     * LPL Financial Holdings Inc  LPLA.O : Jefferies cuts target price to $219 from $224 
     * Marketaxess Holdings Inc  MKTX.O : Credit Suisse cuts target price to $305 from $316 
     * Methode Electronics Inc  MEI.N : Baird cuts target price to $40 from $41 
     * Novartis AG  NVS.N : Jefferies cuts target price to $103 from $106 
     * Pacwest Bancorp  PACW.O : Wells Fargo cuts target price to $45 from $50 
     * Par Pacific Holdings Inc  PARR.N : JP Morgan raises target price to $19 from $17 
     * Pinnacle Financial Partners Inc  PNFP.O : Wells Fargo cuts target price to $115 from $130 
     * Raymond James Financial Inc  RJF.N : Jefferies cuts target price to $108 from $124 
     * Realty Income Corp  O.N : JP Morgan cuts target price to $70 from $75 
     * Rivian Automotive Inc  RIVN.O : CFRA raises target price by $6 to $28 
     * Rover Group Inc  ROVR.O : JP Morgan initiates coverage with neutral rating; PT $5 
     * Sanofi  SNY.O : Jefferies cuts target price to $69 from $72.5 
     * Shopify  SHOP.N : Oppenheimer adjusts PT to $50 from $500 to reflect 10-for-1 stock split 
     * Snap-On Inc  SNA.N : Baird cuts target price to $220 from $233 
     * Tenaris  TS.N : Jefferies raises target price to $46 from $35.7 
     * Visteon Corp  VC.O : Baird cuts target price to $131 from $133 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))